Clinical Observation on Xuesaitong Injection in Treating Senile Cardiovascularand Cerebrovascular Diseases
血塞通注射液治疗老年性心脑血管疾病的临床观察

摘要

目的 探讨临床治疗老年心脑脑血管疾病过程中血塞通注射液的应用效果。方法 选择2022年收治的80例老年心脑血管患者开展研究，根据治疗方案的不同将两组患者均分为对照组及观察组，每组患者40例。以香丹注射液对对照组患者进行干预治疗，观察组患者则采取血塞通注射液进行干预，对两组患者治疗情况进行对比。结果 两组患者在治疗前病情无明显差异，P>0.05。注射治疗积极改善了两组患者的血流流变学指证，且与对照组相比较，观察组指证改善状况更加显著，P<0.05。在治疗总有效率方面相比较，观察组织患者整体治疗效率明显超过对照组，差异显著，P<0.05。结论 在临床治疗老年性心血管疾病的过程中血塞通注射液有效吸收患者血管中的血肿，从而避免对于神经系统造成较大损伤，具有良好的临床应用效果。

Abstract

Objective To investigate the effect of Xuesaitong injection in the clinical treatment of senile cardio cerebral vascular diseases.
Methods 80 elderly patients with cardiovascular and cerebrovascular diseases admitted in 2022 were randomly divided into control group and observation group, with 40 patients in each group. Xiangdan injection was used to intervene the patients in the control group, and Xuesaitong injection was used to intervene the patients in the observation group.
Results There was no significant difference between the two groups before treatment (P>0.05). The injection treatment actively improved the hemorheology indications of the patients in the two groups, and compared with the control group, the improvement of the indications in the observation group was more significant (P<0.05). Compared with the control group in terms of the total effective rate of treatment, the overall therapeutic efficiency of the tissue patients was significantly higher than that of the control group, with a significant difference (P<0.05).
Conclusion   Xuesaitong injection can effectively absorb the hematoma in the blood vessels of patients in the course of clinical treatment of senile cardiovascular diseases, so as to avoid causing greater damage to the nervous system. It has a good clinical application effect.